立即与延迟的齐多夫丁相比.

Same author

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2010

Same author

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

British journal of cancer·2006

Same author

HIV infection and AIDS.

Current opinion in infectious diseases·2006

Same author

HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.

Journal of human virology·2002

Same author

Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers.

Antimicrobial agents and chemotherapy·2001

Same author

Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda.

Journal of acquired immune deficiency syndromes (1999)·2000

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

立即与延迟的齐多夫丁相比.

相关概念视频

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

HIV infection and AIDS.

HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.

Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers.

Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

立即与延迟的齐多夫丁相比.

相关概念视频

相关文章

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

HIV infection and AIDS.

HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.

Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers.

Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.